Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers

The most common breast cancer (BC) susceptibility genes beyond <i>BRCA1/2</i> are <i>ATM</i> and <i>CHEK2</i>. For the purpose of exploring the clinicopathologic characteristics of BC developed by <i>ATM</i> or <i>CHEK2</i> mutation carrier...

Full description

Bibliographic Details
Main Authors:	Angela Toss, Elena Tenedini, Claudia Piombino, Marta Venturelli, Isabella Marchi, Elisa Gasparini, Elena Barbieri, Elisabetta Razzaboni, Federica Domati, Federica Caggia, Giovanni Grandi, Francesca Combi, Giovanni Tazzioli, Massimo Dominici, Enrico Tagliafico, Laura Cortesi
Format:	Article
Language:	English
Published:	MDPI AG 2021-04-01
Series:	Genes
Subjects:	breast cancer <i>ATM</i> <i>CHEK2</i> genetic testing bilateral tumor mastectomy
Online Access:	https://www.mdpi.com/2073-4425/12/5/616

Similar Items

Incidence of the <i>CHEK2</i> Germline Mutation and Its Impact on Clinicopathological Features, Treatment Responses, and Disease Course in Patients with Papillary Thyroid Carcinoma
by: Danuta Gąsior-Perczak, et al.
Published: (2021-01-01)

Characterization of New <i>ATM</i> Deletion Associated with Hereditary Breast Cancer
by: Sandra Parenti, et al.
Published: (2021-01-01)

ATM Kinase Dead: From Ataxia Telangiectasia Syndrome to Cancer
by: Sabrina Putti, et al.
Published: (2021-11-01)

Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D
by: R. Graffeo, et al.
Published: (2022-10-01)

<i>CHEK2</i> Alterations in Pediatric Malignancy: A Single-Institution Experience
by: Eman Abdelghani, et al.
Published: (2023-03-01)

Further Association of Germline <i>CHEK2</i> Loss-of-Function Variants with Testicular Germ Cell Tumors
by: Kira Kirchner, et al.
Published: (2023-11-01)

Genomic Breakpoints’ Characterization of a Large <i>CHEK2</i> Duplication in an Italian Family with Hereditary Breast Cancer
by: Aldo Germani, et al.
Published: (2022-06-01)

Gene Panel Testing for Breast Cancer Reveals Differential Effect of Prior <i>BRCA1/2</i> Probability
by: D. Gareth Evans, et al.
Published: (2021-08-01)

Impact of High-to-Moderate Penetrance Genes on Genetic Testing: Looking over Breast Cancer
by: Antonella Turchiano, et al.
Published: (2023-07-01)

Personalized Systemic Therapies in Hereditary Cancer Syndromes
by: Luciana Mastrodomenico, et al.
Published: (2023-03-01)

Multitumor Case Series of Germline <i>BRCA1</i>, <i>BRCA2</i> and <i>CHEK2</i>-Mutated Patients Responding Favorably on Immune Checkpoint Inhibitors
by: Lisa Kinget, et al.
Published: (2021-08-01)

<i>CHEK2</i> Pathogenic Variants in Greek Breast Cancer Patients: Evidence for Strong Associations with Estrogen Receptor Positivity, Overuse of Risk-Reducing Procedures and Population Founder Effects
by: Paraskevi Apostolou, et al.
Published: (2021-04-01)

Coexisting Germline <i>CHEK2</i> and Somatic <i>BRAF</i><sup>V600E</sup> Mutations in Papillary Thyroid Cancer and Their Association with Clinicopathological Features and Disease Course
by: Danuta Gąsior-Perczak, et al.
Published: (2019-11-01)

Loss of <i>atm</i> in Zebrafish as a Model of Ataxia–Telangiectasia Syndrome
by: Kehua Chen, et al.
Published: (2022-02-01)

<i>CHEK2<sup>p.I157T</sup></i> Mutation Is Associated with Increased Risk of Adult-Type Ovarian Granulosa Cell Tumors
by: Peter Švajdler, et al.
Published: (2022-02-01)

The ATM Gene in Breast Cancer: Its Relevance in Clinical Practice
by: Luigia Stefania Stucci, et al.
Published: (2021-05-01)

Downregulation of ATM and BRCA1 Predicts Poor Outcome in Head and Neck Cancer: Implications for ATM-Targeted Therapy
by: Yu-Chu Wang, et al.
Published: (2021-05-01)

Relationship between the Expression of CHK2 and p53 in Tumor Tissue and the Course of Papillary Thyroid Cancer in Patients with <i>CHEK2</i> Germline Mutations
by: Danuta Gąsior-Perczak, et al.
Published: (2024-02-01)

EMAST Instability and CHEK2 Promoter Analysis in Colorectal Cancer
by: S Rezapour, et al.
Published: (2005-03-01)

EMAST Instability and CHEK2 Promoter Analysis in Colorectal Cancer
by: S Rezapour, et al.
Published: (2005-10-01)

Cancer Cells Haploinsufficient for ATM Are Sensitized to PARP Inhibitors by <i>MET</i> Inhibition
by: Concetta D’Ambrosio, et al.
Published: (2022-05-01)

BRCA Detection Rate in an Italian Cohort of Luminal Early-Onset and Triple-Negative Breast Cancer Patients without Family History: When Biology Overcomes Genealogy
by: Angela Toss, et al.
Published: (2020-05-01)

CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myeloma
by: Chunyan Gu, et al.
Published: (2021-06-01)

Population-Based Estimates of the Age-Specific Cumulative Risk of Breast Cancer for Pathogenic Variants in <i>CHEK2</i>: Findings from the Australian Breast Cancer Family Registry
by: Tú Nguyen-Dumont, et al.
Published: (2021-03-01)

Coping with DNA Double-Strand Breaks via ATM Signaling Pathway in Bovine Oocytes
by: Lili Wang, et al.
Published: (2020-11-01)

<i>atm</i> Mutation and Oxidative Stress Enhance the Pre-Cancerous Effects of UHRF1 Overexpression in Zebrafish Livers
by: Yousra Ajouaou, et al.
Published: (2023-04-01)

A Novel <i>ATM</i> Pathogenic Variant in an Italian Woman with Gallbladder Cancer
by: Elisa De Paolis, et al.
Published: (2021-02-01)

Recurrent Acromegaly in a Patient With a CHEK2 Mutation
by: Milica Perosevic, MD, et al.
Published: (2022-03-01)

Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy
by: Angela Toss, et al.
Published: (2022-12-01)

Bezbednost i zaštita telekomunikacionih širokopojasnih ATM mreža / Security and protection in the broadband ATM telecommunication networks
by: Milojko V. Jevtović, et al.
Published: (2009-10-01)

Bilateral Paget’s Disease of the Breast in a Patient with CHEK2 Mutation
by: Nicci Owusu-Brackett, et al.
Published: (2020-04-01)

CHEK2 mutations and papillary thyroid cancer: correlation or coincidence?
by: Kortbeek Koen, et al.
Published: (2022-01-01)

Characterization of Aberrations in DNA Damage Repair Pathways in Gastrointestinal Stromal Tumors: The Clinicopathologic Relevance of γH2AX and 53BP1 in Correlation with Heterozygous Deletions of <i>CHEK2</i>, <i>BRCA2</i>, and <i>RB1</i>
by: Ting-Ting Liu, et al.
Published: (2022-03-01)

Otsenka effektivnosti i bezopasnosti ispol'zovaniya insulinovykh pomp Accu-Chek
by: Andrey Olegovich Emel'yanov, et al.
Published: (2008-09-01)

Kinase-dead ATM protein is highly oncogenic and can be preferentially targeted by Topo-isomerase I inhibitors
by: Kenta Yamamoto, et al.
Published: (2016-06-01)

Multiple Primary Melanoma in a CHEK2 Mutation Carrier
by: Álvarez-Salafranca Marcial, et al.
Published: (2023-07-01)

Novel <i>ATM</i> Gene c.5644 C > T (p.Arg1882*) Variant Detected in a Patient with Pancreatic Adenocarcinoma and Two Primary Non-Small Cell Lung Adenocarcinomas: A Case Report
by: Abed A. Aljamal, et al.
Published: (2022-12-01)

Contralateral Prophylactic Mastectomy in Women with Unilateral Breast Cancer Who Are Genetic Carriers, Have a Strong Family History or Are just Young at Presentation
by: Victoria Teoh, et al.
Published: (2020-01-01)

A Rare Variant in <i>MDH2</i> (rs111879470) Is Associated with Predisposition to Recurrent Breast Cancer in an Extended High-Risk Pedigree
by: Lisa A. Cannon-Albright, et al.
Published: (2023-12-01)

Are Mutation Carrier Patients Different from Non-Carrier Patients? Genetic, Pathology, and US Features of Patients with Breast Cancer
by: Roxana Maria Pintican, et al.
Published: (2022-06-01)